Inventor
CHANG MING-SHI
US41 patents
⚠️ This page may combine multiple inventors who share the name “CHANG MING-SHI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
15 patentsUS6284485B1Sep 4, 2001
Nucleic acids encoding osteoprotegerin
AMGEN INC123 citations98
US6015938AJan 18, 2000
Osteoprotegerin
AMGEN INC158 citations98
US6369027B1Apr 9, 2002
Osteoprotegerin
AMGEN INC65 citations96
US6288032B1Sep 11, 2001
Osteoprotegerin
AMGEN INC56 citations96
US6284740B1Sep 4, 2001
Osteoprotegerin
AMGEN INC56 citations96
US6284728B1Sep 4, 2001
Osteoprotegerin
AMGEN INC57 citations96
US6613544B1Sep 2, 2003
Osteoprotegerin
AMGEN INC20 citations92
US6143874ANov 7, 2000
Antibodies to the neurotrophic factor NNT-1
AMGEN INC21 citations92
US5741772AApr 21, 1998
Neurotrophic factor NNT-1
AMGEN INC21 citations92
US7005413B1Feb 28, 2006
Combination therapy for conditions leading to bone loss
AMGEN INC16 citations82
US6054294AApr 25, 2000
Nucleic acid molecules encoding the neurotrophic factor NNT-1
AMGEN INC14 citations82
US8344110B2Jan 1, 2013
Antibodies to thymic stromal lymphopoietin (TSLP) receptor molecules and uses thereof
AMGEN INC10 citations81
US7964713B2Jun 21, 2011
Nucleic acid molecules encoding thymic stromal lympopoietin receptor proteins and a process for producing the encoded polypeptides thereof
AMGEN INC1 citations60
US8911730B2Dec 16, 2014
Methods of using antibodies to block human thymic stromal lymphopoietin (TSLP) receptor activity
AMGEN INC1 citations59
US7632922B1Dec 15, 2009
Osteoprotegerin
AMGEN INC1 citations52
UNIV NAT CHENG KUNG
13 patentsUS7837994B2Nov 23, 2010
Use of anti-IL-20 antibody for treating osteoporosis
UNIV NAT CHENG KUNG16 citations92
US7611705B2Nov 3, 2009
Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases
UNIV NAT CHENG KUNG33 citations92
US8377441B2Feb 19, 2013
Treating breast cancer with anti-IL-19 antibody
UNIV NAT CHENG KUNG15 citations84
US8012478B2Sep 6, 2011
Use of anti-IL-20 antibody for treating stroke
UNIV NAT CHENG KUNG13 citations84
US7786274B2Aug 31, 2010
Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases
UNIV NAT CHENG KUNG12 citations84
US9217031B2Dec 22, 2015
Humanized anti-IL-20 antibody and uses thereof
UNIV NAT CHENG KUNG2 citations63
US9982043B2May 29, 2018
Use of IL-20 antagonists for treating pancreatic cancer
UNIV NAT CHENG KUNG0 citations52
US9683036B2Jun 20, 2017
Humanized anti-IL-20 antibody and uses thereof
UNIV NAT CHENG KUNG0 citations52
US9365652B2Jun 14, 2016
Use of IL-20 antagonists for treating liver diseases
UNIV NAT CHENG KUNG0 citations52
US9221904B2Dec 29, 2015
Treatment of osteoarthritis using IL-20 antagonists
UNIV NAT CHENG KUNG1 citations52
US9751949B2Sep 5, 2017
Method of inhibiting adipogenesis with an IL-20 antibody
UNIV NAT CHENG KUNG0 citations51
US9512218B2Dec 6, 2016
Use of IL-20 antagonists for alleviating spinal cord injury
UNIV NAT CHENG KUNG0 citations46
US9376490B2Jun 28, 2016
Treatment of inflammatory pain using IL-20 antagonists
UNIV NAT CHENG KUNG0 citations46
CHANG MING-SHI
7 patentsUS8603470B1Dec 10, 2013
Use of IL-20 antagonists for treating liver diseases
CHANG MING-SHI13 citations84
US8597647B1Dec 3, 2013
Humanized anti-IL-20 antibody and uses thereof
CHANG MING-SHI12 citations84
US8454956B2Jun 4, 2013
Methods for treating rheumatoid arthritis and osteoporosis with anti-IL-20 antibodies
CHANG MING-SHI8 citations84
US8206712B2Jun 26, 2012
Use of anti-IL-20 antibody for treating rheumatoid arthritis
CHANG MING-SHI8 citations84
US9127066B2Sep 8, 2015
Methods for treating osteoporosis with anti-IL-20 receptor antibodies
CHANG MING-SHI2 citations62
US8852588B2Oct 7, 2014
Treating allergic airway disorders using anti-IL-20 receptor antibodies
CHANG MING-SHI2 citations62
US8535674B2Sep 17, 2013
Treating breast cancer and inhibiting cancer-associated bone loss with anti-IL-20 antibody
CHANG MING-SHI2 citations62
LBL BIOTECHNOLOGY INC
3 patentsUS12409208B2Sep 9, 2025
Treating tissue fibrosis with interleukin 24
LBL BIOTECHNOLOGY INC0 citations59
US11661450B2May 30, 2023
Combination therapy using an IL-20 antagonist and an immune checkpoint inhibitor
LBL BIOTECHNOLOGY INC0 citations59
US11279755B2Mar 22, 2022
Use of IL-20 antagonists for treating eye diseases
LBL BIOTECHNOLOGY INC0 citations59